Equities

JMDC Inc

JMDC Inc

Actions
  • Price (EUR)17.60
  • Today's Change-0.10 / -0.56%
  • Shares traded-1.00
  • 1 Year change-55.10%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024 07:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

JMDC Inc. is a Japan-based company mainly engaged in the health big data business, telemedicine business and dispensing pharmacy support business. The Company operates in three business segments. The Health Big Data segment is engaged in the provision of receipt data analysis and health promotion solutions, and personal health information platforms, the build, management and analysis of medical databases such as receipt data and medical examination data, the build and sale of drug databases, and the development and provision of systems using drug databases for medical institutions. The Telemedicine segment is engaged in the provision of remote image diagnosis matching services, and infrastructure systems for remote image diagnosis. The Dispensing Pharmacy Support segment is engaged in the development and provision of business systems and electronic medication record for dispensing pharmacies, as well as the operation of dispensing pharmacies.

  • Revenue in JPY (TTM)32.38bn
  • Net income in JPY4.61bn
  • Incorporated2002
  • Employees1.48k
  • Location
    JMDC Inc2F, Kojimachi 311 Bldg, 3-1, KojimachiMINATO-KU 105-0012JapanJPN
  • Phone+81 357335010
  • Fax+81 357335101
  • Websitehttps://www.jmdc.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4483:TYO since
announced
Transaction
value
Cancerscan IncDeal completed28 Dec 202328 Dec 2023Deal completed-32.71%100.12m
Data delayed at least 20 minutes, as of May 17 2024 07:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.